These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18069389

  • 1. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S, Bartoszcze M, Gryko R.
    Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
    [Abstract] [Full Text] [Related]

  • 2. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B.
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [Abstract] [Full Text] [Related]

  • 3. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR, Marvaud JC, Raffestin S.
    Ann Pharm Fr; 2001 May 01; 59(3):176-90. PubMed ID: 11427819
    [Abstract] [Full Text] [Related]

  • 5. In vitro physiological studies on clostridial neurotoxins. Biological models and procedures for extracellular and intracellular application of toxins.
    Poulain B, Bader MF, Molgó J.
    Methods Mol Biol; 2000 May 01; 145():259-86. PubMed ID: 10820727
    [No Abstract] [Full Text] [Related]

  • 6. [Structure and function of botulinum toxin].
    Fujii N.
    Hokkaido Igaku Zasshi; 1995 Jan 01; 70(1):19-28. PubMed ID: 7744367
    [Abstract] [Full Text] [Related]

  • 7. Cell entry strategy of clostridial neurotoxins.
    Binz T, Rummel A.
    J Neurochem; 2009 Jun 01; 109(6):1584-95. PubMed ID: 19457120
    [Abstract] [Full Text] [Related]

  • 8. Engineered toxins: new therapeutics.
    Foster KA.
    Toxicon; 2009 Oct 01; 54(5):587-92. PubMed ID: 19264086
    [Abstract] [Full Text] [Related]

  • 9. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun 01; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F, Humeau Y, Vitiello F, Popoff MR, Poulain B.
    J Soc Biol; 1999 Jun 01; 193(6):457-67. PubMed ID: 10783704
    [Abstract] [Full Text] [Related]

  • 11. [Clostridium botulinum and botulinum neurotoxin].
    Hirai Y.
    Brain Nerve; 2011 Jul 01; 63(7):755-61. PubMed ID: 21747146
    [Abstract] [Full Text] [Related]

  • 12. Functional characterisation of tetanus and botulinum neurotoxins binding domains.
    Lalli G, Herreros J, Osborne SL, Montecucco C, Rossetto O, Schiavo G.
    J Cell Sci; 1999 Aug 01; 112 ( Pt 16)():2715-24. PubMed ID: 10413679
    [Abstract] [Full Text] [Related]

  • 13. Sequence homology and structural analysis of the clostridial neurotoxins.
    Lacy DB, Stevens RC.
    J Mol Biol; 1999 Sep 03; 291(5):1091-104. PubMed ID: 10518945
    [Abstract] [Full Text] [Related]

  • 14. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B, Lonchamp E, Jover E, Popoff MR, Molgó J.
    Ann Dermatol Venereol; 2009 May 03; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [Abstract] [Full Text] [Related]

  • 15. Clostridial neurotoxins: from toxins to therapeutic tools?
    Niemann H, Binz T, Grebenstein O, Kurazono H, Thierer J, Mochida S, Poulain B, Tauc L.
    Behring Inst Mitt; 1991 Jul 03; (89):153-62. PubMed ID: 1930094
    [Abstract] [Full Text] [Related]

  • 16. Molecular pharmacology of botulinum toxin and tetanus toxin.
    Simpson LL.
    Annu Rev Pharmacol Toxicol; 1986 Jul 03; 26():427-53. PubMed ID: 3521461
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
    Poulain B, Mochida S, Wadsworth JD, Weller U, Habermann E, Dolly JO, Tauc L.
    J Physiol (Paris); 1990 Jul 03; 84(4):247-61. PubMed ID: 1981913
    [Abstract] [Full Text] [Related]

  • 18. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
    Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, Montecucco C.
    Nature; 1992 Oct 29; 359(6398):832-5. PubMed ID: 1331807
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL, Dasgupta BR.
    J Pharmacol Exp Ther; 1983 Jan 29; 224(1):135-40. PubMed ID: 6294275
    [Abstract] [Full Text] [Related]

  • 20. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.
    Turton K, Chaddock JA, Acharya KR.
    Trends Biochem Sci; 2002 Nov 29; 27(11):552-8. PubMed ID: 12417130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.